iShares Biotechnology ETF (IBB) offers targeted exposure to the U.S. biotechnology sector, providing investors with access to ...
Zacks Investment Research on MSN
Biotech ETFs Hovering Around a 52-Week: Here's Why
Biotech-based exchange-traded fund (ETF) iShares Biotechnology ETF IBB has rallied 26.1% over the past six months (as of Oct. 27, 2025), outperforming SPDR S&P 500 ETF Trust SPY (up 24.4%). Year to ...
The Vanguard FTSE Developed Markets ETF tracks the FTSE Developed All Cap ex U.S. index. The SPDR Portfolio Developed World ...
2. Mergers and acquisitions are picking up: So far this year, buyouts have boosted several biotech stocks. Some standouts: ...
Zacks.com on MSN
Want to Ride the Halloween Effect: ETF Strategies to Follow
It's time for the Halloween Effect! Check out ETFs like IYG, IYF, KBWB, XLV, XBI, SMH, FTXL, SPSM & VIOO that could shine from November -- April!
News archive including articles on Fund Managers, Fund Selection, Asset Allocation, Absolute Return, Offshore Investments, ...
With all the AI bubble headlines out there, it’s easy to conclude that the great bull run will end in tears and perhaps ...
On the selling side, ARK divested 38,338 shares of Palantir Technologies Inc (NYSE:PLTR) through its ARKK ETF, with the sale totaling $7,685,618. This marks a continuation of ARK’s recent reduction of ...
Detailed price information for Unitedhealth Group Inc (UNH-N) from The Globe and Mail including charting and trades.
On the sell side, ARK trimmed its holdings in several companies, with the most notable sale being 61,072 shares of SHOPIFY INC (NYSE:SHOP), valued at $10,691,264. This followed a pattern of reducing ...
ETC 6 Meridian Mega Cap Equity ETF offers defensive, value-tilted portfolio focused on high-quality, large-cap US companies.
It is an animal menagerie when it comes to China’s tech scene, from little dragons to AI tigers. For the uninitiated, the most familiar name will likely be the “BATs”, Baidu, Alibaba and Tencent.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results